Invictus MD Strategies Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Invictus MD Strategies's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
Pharmaceuticals Industry Growth | 6.0% |
Revenue growth rate | n/a |
Return on equity | n/a |
Net Margin | n/a |
Last Earnings Update | 31 Oct 2019 |
Recent past performance updates
No updates
Recent updates
Revenue & Expenses Breakdown
How Invictus MD Strategies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Oct 19 | 7 | -34 | 7 | 0 |
31 Jul 19 | 7 | -37 | 15 | 0 |
30 Apr 19 | 5 | -37 | 20 | 0 |
31 Jan 19 | 5 | -36 | 18 | 0 |
31 Oct 18 | 2 | -17 | 24 | 0 |
31 Jul 18 | 1 | -19 | 16 | 0 |
30 Apr 18 | 3 | -16 | 13 | 0 |
31 Jan 18 | 2 | -20 | 15 | 0 |
31 Oct 17 | 2 | -28 | 15 | 0 |
31 Jul 17 | 2 | -16 | 13 | 0 |
30 Apr 17 | 2 | -14 | 12 | 0 |
31 Jan 17 | 3 | -6 | 6 | 0 |
31 Oct 16 | 4 | -1 | 3 | 0 |
31 Jul 16 | 5 | -1 | 3 | 0 |
30 Apr 16 | 5 | 0 | 2 | 0 |
31 Jan 16 | 4 | 0 | 2 | 0 |
31 Oct 15 | 2 | -2 | 1 | 0 |
31 Jul 15 | 0 | -1 | 1 | 0 |
30 Apr 15 | 0 | -1 | 0 | 0 |
31 Jan 15 | 0 | -1 | 0 | 0 |
Quality Earnings: Insufficient data to determine if IVIT.F has high quality earnings.
Growing Profit Margin: Insufficient data to determine if IVIT.F's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if IVIT.F's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare IVIT.F's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if IVIT.F's earnings growth over the past year exceeded the Pharmaceuticals industry average.
Return on Equity
High ROE: IVIT.F has a negative Return on Equity (0%), as it is currently unprofitable.